4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
4.210
-0.150 (-3.44%)
At close: Jul 18, 2025, 4:00 PM
4.220
+0.010 (0.24%)
After-hours: Jul 18, 2025, 4:04 PM EDT
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $195.03 million as of July 18, 2025. Its market cap has decreased by -82.32% in one year.
Market Cap
195.03M
Enterprise Value
-240.95M
1-Year Change
-82.32%
Ranking
Category
Stock Price
$4.21
Market Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has decreased from $580.38M to $195.03M, a decrease of -66.40%. That is a compound annual growth rate of -21.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2025 | 201.98M | -21.56% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | 1.10B | 89.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 693.39B |
| Johnson & Johnson | 395.29B |
| AbbVie | 334.20B |
| Novo Nordisk | 292.40B |
| UnitedHealth Group | 255.61B |
| Novartis AG | 224.54B |
| Abbott Laboratories | 216.59B |
| AstraZeneca | 214.61B |